跳至主要内容
临床试验/NCT04975373
NCT04975373Unknown不适用

Reduction of Intrauterine Adhesions by Intrauterine Hyaluronic Acid Gel After Hysteroscopic Removal of Retained Products of Conception: Multicenter Prospective Randomized Trial

Barzilai Medical Center1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2021年6月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
160
试验地点
1
主要终点
any adhesions

研究概览

简要总结

Women undergoing operative hysteroscopy for removal of retained placenta after delivery will be randomized into two groups.

  1. study group - immediately after operative hysteroscopy 5 ml hyaluronic acid gel will be injected into uterine cavity
  2. control group - no injection

4-8 weeks after operative hysteroscopy, participants will undergo diagnostic hysteroscopy with no anesthesia , as a part of routine evaluation after removal of retained placenta in Israel.

during diagnostic hysteroscopy the uterine cavity will be evaluated and the presence of adhesions and severity of adhesions will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women undergoing hysteroscopic removal of retained placenta after delivery

排除标准

  • Known adverse reaction or allergy to hyaluronic acid
  • History of intrauterine adhesions
  • Acute pelvic inflammatory disease

研究组 & 干预措施

study group

Other

study group women in this group will receive intrauterine hyaluronic acid injection after operative hysteroscopy

干预措施: Intrauterine injection of hyaluronic acid (Drug)

结局指标

主要结局

any adhesions

时间窗: 4-8 weeks after intervention

presence of any adhesions in uterine cavity during diagnostic hysteroscopy

次要结局

  • adhesion scorring(4-8 weeks after intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验